The Hopeful ADHD Implications of Fasoracetam
If you have followed the nootropic industry for any period of time, you’ve probably heard of piracetam. Though certainly not the first time humans altered brain chemistry, it was this synthetic drug that sparked the term “nootropics” in the first place.
Given that it is the grandfather of nootropics and the racetam family as a whole, it is no wonder most people in this community have already heard of the drug. Nonetheless, there are far more lesser known drugs available in a legal grey area, which have significantly different effects on the brain.
Other options like aniracetam and oxiracetam are slightly less common, but relatively well-known. These have drastically different metabolic pathways meaning that they interact with our brain differently than the structurally similar piracetam.
Most of these are useful for memory and cognition though the studies focus primarily on the benefits for the neurodegeneration and reversing the cognitive signs of aging.
Yet, within this same family of drugs there are a host of advantageous nootropic compounds for other aspects of cognition altogether. One of these is fasoracetam.
Fasoracetam is yet another iteration of the piracetam family, but has just finished testing for the purposes of ADHD treatment. In June 2016, studies began to test whether fasoracetam could help treat the symptoms of ADHD and as of December, the study was completed.
While there is no way to know the results before they are published, one thing remains true. The fact it is considered for this purpose is telling. Fasoracetam is also a cholinergic compound meaning it interacts with a completely different aspect of brain chemistry than most ADHD medications.
Given that 11% of American children ages 4–17 are taking an amphetamine-based drug to treat ADHD, the alternative of a cholinergic like fasoracetam could be big news. As it is, I’ve already found phenylpiracetam removes aspects of inattentiveness according to my recent QEEG visit at the Peak Brain Institute.
It is a step in the right direction, but only if it becomes more widely available. Sure, there are people who need medications as strong as Adderall in order to function, but these aren’t the norm.